Developing lysosome-targeting organic nanoparticles combined with photoacoustic imaging (PAI) and photodynamic therapy (PDT) functions toward personalized medicine are highly desired yet challenging. Here, for the first time, lysosome-targeting BODIPY nanoparticles were engineered by encapsulating near-infrared (NIR) absorbed BODIPY dye within amphiphilic DSPE-mPEG5000 for high-performing lysosomal PAI and acid-activatable PDT against cancer cells under NIR light.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.6b02721 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!